Logo image of CLRO

CLEARONE INC (CLRO) Stock Fundamental Analysis

NASDAQ:CLRO - Nasdaq - US18506U1043 - Common Stock - Currency: USD

0.48  -0.03 (-5.97%)

After market: 0.46 -0.02 (-4.17%)

Fundamental Rating

2

Taking everything into account, CLRO scores 2 out of 10 in our fundamental rating. CLRO was compared to 49 industry peers in the Communications Equipment industry. CLRO has a great financial health rating, but its profitability evaluates not so good. CLRO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CLRO had negative earnings in the past year.
CLRO had a negative operating cash flow in the past year.
In multiple years CLRO reported negative net income over the last 5 years.
CLRO had negative operating cash flow in 4 of the past 5 years.
CLRO Yearly Net Income VS EBIT VS OCF VS FCFCLRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

The Return On Assets of CLRO (-33.84%) is worse than 77.55% of its industry peers.
The Return On Equity of CLRO (-42.11%) is worse than 67.35% of its industry peers.
Industry RankSector Rank
ROA -33.84%
ROE -42.11%
ROIC N/A
ROA(3y)-3.47%
ROA(5y)-4.24%
ROE(3y)-5.21%
ROE(5y)-5.91%
ROIC(3y)N/A
ROIC(5y)N/A
CLRO Yearly ROA, ROE, ROICCLRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

CLRO has a worse Gross Margin (23.09%) than 85.71% of its industry peers.
In the last couple of years the Gross Margin of CLRO has declined.
The Profit Margin and Operating Margin are not available for CLRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.52%
GM growth 5Y-12.37%
CLRO Yearly Profit, Operating, Gross MarginsCLRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

7

2. Health

2.1 Basic Checks

CLRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLRO has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CLRO has been increased compared to 5 years ago.
There is no outstanding debt for CLRO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLRO Yearly Shares OutstandingCLRO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CLRO Yearly Total Debt VS Total AssetsCLRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 0.97, we must say that CLRO is in the distress zone and has some risk of bankruptcy.
CLRO has a Altman-Z score of 0.97. This is comparable to the rest of the industry: CLRO outperforms 51.02% of its industry peers.
CLRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.97
ROIC/WACCN/A
WACC9.92%
CLRO Yearly LT Debt VS Equity VS FCFCLRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

CLRO has a Current Ratio of 5.29. This indicates that CLRO is financially healthy and has no problem in meeting its short term obligations.
CLRO's Current ratio of 5.29 is amongst the best of the industry. CLRO outperforms 91.84% of its industry peers.
A Quick Ratio of 2.12 indicates that CLRO has no problem at all paying its short term obligations.
The Quick ratio of CLRO (2.12) is better than 73.47% of its industry peers.
Industry RankSector Rank
Current Ratio 5.29
Quick Ratio 2.12
CLRO Yearly Current Assets VS Current LiabilitesCLRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

CLRO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1801.02%.
Looking at the last year, CLRO shows a very negative growth in Revenue. The Revenue has decreased by -39.13% in the last year.
The Revenue for CLRO have been decreasing by -14.58% on average. This is quite bad
EPS 1Y (TTM)-1801.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-183.05%
Revenue 1Y (TTM)-39.13%
Revenue growth 3Y-26.75%
Revenue growth 5Y-14.58%
Sales Q2Q%-28.84%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CLRO Yearly Revenue VS EstimatesCLRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CLRO Yearly EPS VS EstimatesCLRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 0 0.2 0.4 0.6 0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CLRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLRO Price Earnings VS Forward Price EarningsCLRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CLRO Per share dataCLRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLRO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEARONE INC

NASDAQ:CLRO (5/21/2025, 8:00:00 PM)

After market: 0.46 -0.02 (-4.17%)

0.48

-0.03 (-5.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)04-22 2025-04-22
Earnings (Next)05-27 2025-05-27
Inst Owners6.12%
Inst Owner Change-5.65%
Ins Owners0.25%
Ins Owner Change14.52%
Market Cap12.48M
Analysts85.71
Price TargetN/A
Short Float %0.73%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.6
Dividend Growth(5Y)24.47%
DP-161.37%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.1
P/FCF N/A
P/OCF N/A
P/B 0.58
P/tB 0.63
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.44
BVpS0.82
TBVpS0.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.84%
ROE -42.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.09%
FCFM N/A
ROA(3y)-3.47%
ROA(5y)-4.24%
ROE(3y)-5.21%
ROE(5y)-5.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.52%
GM growth 5Y-12.37%
F-Score3
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34%
Cap/Sales 2.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.29
Quick Ratio 2.12
Altman-Z 0.97
F-Score3
WACC9.92%
ROIC/WACCN/A
Cap/Depr(3y)26.17%
Cap/Depr(5y)23.5%
Cap/Sales(3y)2.06%
Cap/Sales(5y)1.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1801.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-183.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-39.13%
Revenue growth 3Y-26.75%
Revenue growth 5Y-14.58%
Sales Q2Q%-28.84%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-111.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-111.2%
OCF growth 3YN/A
OCF growth 5YN/A